UPDATE: Galena Biopharma (GALE) Stock Hit
Tweet
Share
E-mailGet Alerts GALE Hot Sheet
Join SI Premium – FREE
(Updated - February 14, 2014 11:18 AM EST)
Galena Biopharma (Nasdaq: GALE) came under pressure early on Friday. The stock didn't look healthy pre-market and sentiment turned further south following a negative piece by a short seller posted on Seeking Alpha. The article warns the stock may finish the year below $1 per share. Link
The stock weakened early in the week after TheStreet.com's Adam Feuerstein published a blistering accusation of the company, claiming the stock was being pumped. Link Here. The story was recently updated.
Galena shares are down 26%.
Galena Biopharma (Nasdaq: GALE) came under pressure early on Friday. The stock didn't look healthy pre-market and sentiment turned further south following a negative piece by a short seller posted on Seeking Alpha. The article warns the stock may finish the year below $1 per share. Link
The stock weakened early in the week after TheStreet.com's Adam Feuerstein published a blistering accusation of the company, claiming the stock was being pumped. Link Here. The story was recently updated.
Galena shares are down 26%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Pelican Way Research shorts Hyliion Holdings (HYLN) on VFG deal concerns
- Gildan responds to short seller report, reiterates 2026 guidance
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Create E-mail Alert Related Categories
Insiders' Blog, Short Sales, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
